Cabot Corporation (NYSE:CBT)‘s stock had its “hold” rating restated by equities researchers at KeyCorp in a report issued on Wednesday.

A number of other equities research analysts also recently issued reports on the company. Loop Capital began coverage on Cabot Corporation in a research report on Thursday, September 28th. They set a “hold” rating and a $59.00 price target for the company. Zacks Investment Research raised Cabot Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 16th. J P Morgan Chase & Co raised Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price target for the company in a research report on Tuesday, August 15th. BidaskClub downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, ValuEngine cut Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Friday, July 28th. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $60.29.

Cabot Corporation (NYSE:CBT) traded up 4.23% during trading on Wednesday, reaching $63.54. The company had a trading volume of 347,629 shares. The company has a market capitalization of $3.95 billion, a P/E ratio of 17.80 and a beta of 1.09. The firm’s 50 day moving average is $57.02 and its 200-day moving average is $54.55. Cabot Corporation has a 12 month low of $47.99 and a 12 month high of $64.14.

Cabot Corporation (NYSE:CBT) last posted its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.93 by ($0.02). Cabot Corporation had a net margin of 8.61% and a return on equity of 16.03%. The firm had revenue of $723.00 million for the quarter, compared to analysts’ expectations of $683.30 million. During the same period last year, the firm posted $1.00 EPS. Cabot Corporation’s revenue was up 16.8% on a year-over-year basis. On average, equities analysts expect that Cabot Corporation will post $3.44 earnings per share for the current year.

WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/01/keycorp-reaffirms-hold-rating-for-cabot-corporation-cbt.html.

In other Cabot Corporation news, insider Hobart Kalkstein sold 3,881 shares of the business’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $53.39, for a total transaction of $207,206.59. Following the transaction, the insider now owns 27,736 shares in the company, valued at $1,480,825.04. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.50% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of CBT. World Asset Management Inc lifted its stake in shares of Cabot Corporation by 0.5% in the first quarter. World Asset Management Inc now owns 4,333 shares of the specialty chemicals company’s stock worth $260,000 after acquiring an additional 20 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Cabot Corporation by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,118 shares of the specialty chemicals company’s stock worth $487,000 after acquiring an additional 33 shares in the last quarter. Teacher Retirement System of Texas lifted its stake in shares of Cabot Corporation by 0.9% in the second quarter. Teacher Retirement System of Texas now owns 4,984 shares of the specialty chemicals company’s stock worth $266,000 after acquiring an additional 45 shares in the last quarter. Northwestern Mutual Investment Management Company LLC lifted its stake in shares of Cabot Corporation by 0.5% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 10,772 shares of the specialty chemicals company’s stock worth $492,000 after acquiring an additional 54 shares in the last quarter. Finally, Bbva Compass Bancshares Inc. lifted its stake in shares of Cabot Corporation by 0.9% in the second quarter. Bbva Compass Bancshares Inc. now owns 9,086 shares of the specialty chemicals company’s stock worth $415,000 after acquiring an additional 82 shares in the last quarter. Institutional investors own 84.32% of the company’s stock.

About Cabot Corporation

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Analyst Recommendations for Cabot Corporation (NYSE:CBT)

Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.